Mandate

Vinge has advised Azelio in connection with its rights issue

Vinge has advised Azelio AB (publ) on a fully guaranteed rights issue, which will provide Azelio with issue proceeds amounting to approximately SEK 300 million before deduction of transaction costs.

The new shares and warrants issued by reason of the rights issue are expected to be admitted to trading on Nasdaq First North Growth Market on 31 October 2022.

Azelio is a public Swedish company, specializing in in energy storage with electricity and heat production. Azelio’s system (“TES.POD “) for renewable, Stirling-based electricity production and heat production is based on continuous technological development and refinement. The technology makes the energy dispatchable, enabling renewable energy to be made available around-the-clock.

Azelio’s shares are listed on Nasdaq First North Growth Market.

Vinge’s team consisted primarily of David Andersson, William Kåge, Joel Magnusson, Benjamin Vafaeian and Joacim Malmqvist.

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026